Home › Pneumonia › California › San Diego
Pneumonia clinical trials in San Diego, CA
3 studies for Pneumonia are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- UC San Diego Medical Center - Hillcrest, San Diego
- University of California San Diego Health, San Diego
- Jacobs Medical Center at UC San Diego Health, La Jolla · 11 mi away
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RecruitingObservational study
- Kaiser Permanente Zion Medical Center, San Diego
- Kaiser Permanente San Diego Medical Center, San Diego
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, San Diego
About Pneumonia
Pneumonia is an infection in one or both of the lungs. Symptoms of pneumonia vary to mild to severe. Read about the signs of pneumonia.
More about Pneumonia on MedlinePlus
Pneumonia trials in other cities
- Houston, TX8 studies
- Salt Lake City, UT6 studies
- Chicago, IL6 studies
- Boston, MA5 studies
- Durham, NC5 studies
- Washington, DC5 studies
- Cincinnati, OH4 studies
- Los Angeles, CA4 studies
- Dallas, TX4 studies
- Hialeah, FL4 studies
- St. Louis, MO4 studies
- Philadelphia, PA4 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer25 studies
- Ovarian Cancer24 studies
- Pancreatic Cancer24 studies
- Lung Cancer23 studies
- Obesity23 studies
- Heart Failure23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.